Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 306,459 | 272,330 | 255,058 | 195,053 | 186,581 |
| Cost of Goods | 123,459 | 115,306 | 97,991 | 71,344 | 73,941 |
| Gross Profit | 183,000 | 157,024 | 157,067 | 123,709 | 112,640 |
| Operating Expenses | 206,497 | 200,428 | 288,067 | 229,208 | 81,551 |
| Operating Income | -23,038 | -43,098 | -130,009 | -105,155 | 32,030 |
| Other Income | 3,439 | 4,025 | 5,211 | 6,025 | 8,514 |
| Pre-tax Income | -19,599 | -39,073 | -124,798 | -99,130 | 40,544 |
| Income Tax | 11,216 | 616 | 582 | 1,786 | 14,234 |
| Net Income Continuous | -30,815 | -39,689 | -125,380 | -100,916 | 26,310 |
| Net Income | $-30,815 | $-39,689 | $-125,380 | $-100,916 | $26,310 |
| EPS Basic Total Ops | -0.18 | -0.22 | -0.68 | -0.54 | 0.14 |
| EPS Basic Continuous Ops | -0.17 | -0.22 | -0.68 | -0.55 | 0.14 |
| EPS Diluted Total Ops | -0.18 | -0.22 | -0.68 | -0.54 | 0.14 |
| EPS Diluted Continuous Ops | -0.17 | -0.22 | -0.68 | -0.55 | 0.14 |
| EPS Diluted Before Non-Recurring Items | -0.08 | -0.11 | -0.34 | -0.07 | -0.15 |
| EBITDA(a) | $-11,070 | $-37,219 | $-124,155 | $-99,956 | $38,432 |